Skip to content

Effect of propofol and remazolam at induction doses of anesthesia on systolic and diastolic function of the heart in the elderly

Effect of propofol and remazolam at induction doses of anesthesia on systolic and diastolic function of the heart in the elderly

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099283
Enrollment
Unknown
Registered
2025-03-20
Start date
2023-09-11
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Under general anesthesia

Interventions

Remazolam group:Induction dosing of remazolam was administered intravenously
Propofol group:Induction dosing of propofol was administered intravenously

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age>=65 years; 2. ASA classification I-III 3. Those who can cooperate with transthoracic ultrasound; 4. Patients and their families understand and voluntarily sign the informed consent form; 5. Elective endotracheal intubation under general anesthesia is planned.

Exclusion criteria

Exclusion criteria: 1.ASA grade IV to V; 2.Ejection fraction (EF)&lt upon admission; 40%, acute active varicose bleeding; 3.Hepatic encephalopathy; 4.Neurological diseases such as alzheimer's disease or Parkinson's disease; 5.Peripheral hemorrhage shock; 6.Allergy to benzodiazepines or propofol; 7.Refused to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
Ejection fraction (EF%);Ratio of early to late diastolic mitral flow velocity (E/A);

Secondary

MeasureTime frame
Maximal early diastolic mitral annular velocity (e ');Maximal mitral annular velocity in late diastole (a ');Blood pressure and heart rate product;Stroke volume;Left atrial volume index;Velocity of tricuspid regurgitation;The collapse index of the inferior vena cava;

Countries

China

Contacts

Public ContactLei Hongyi

Zhujiang Hospital of Southern Medical University

leihongyi2012@163.com+86 20 61643888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026